首页 > 最新文献

Osong Public Health and Research Perspectives最新文献

英文 中文
It is time to hold discussions with policymakers. 现在是与决策者进行讨论的时候了。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2025-02-27 DOI: 10.24171/j.phrp.2025.0057
Jong-Koo Lee
{"title":"It is time to hold discussions with policymakers.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2025.0057","DOIUrl":"10.24171/j.phrp.2025.0057","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"16 1","pages":"1-2"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143617541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polycystic ovary syndrome, cardiovascular risk, and coffee: a complex interplay. 多囊卵巢综合征、心血管风险和咖啡:复杂的相互作用。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2025-02-17 DOI: 10.24171/j.phrp.2025.0004
Anna Vittoria Mattioli
{"title":"Polycystic ovary syndrome, cardiovascular risk, and coffee: a complex interplay.","authors":"Anna Vittoria Mattioli","doi":"10.24171/j.phrp.2025.0004","DOIUrl":"10.24171/j.phrp.2025.0004","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"89-90"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics and trends of severe/critical COVID-19 cases in the Republic of Korea (January 2020 to August 2023). 2020年1月至2023年8月韩国COVID-19重/危重病例特征和趋势
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2025-02-07 DOI: 10.24171/j.phrp.2024.0295
Se-Jin Jeong, Shin Young Park, Boyeong Ryu, Misuk An, Jin-Hwan Jeon, So Young Choi, Seong-Sun Kim

Background: We analyzed the demographic and clinical characteristics of patients diagnosed with coronavirus disease 2019 (COVID-19), focusing specifically on severe/critical cases, and assessed the trends and rates of severity and fatality among these patients in the Republic of Korea.

Methods: Clinical data on patients with COVID-19 from January 20, 2020 to August 30, 2023 were collected from the Korea Disease Control and Prevention Agency's database. We identified patients who progressed to severe/critical conditions and analyzed their demographic and clinical profiles. Severity and fatality rates were calculated and compared annually to track the disease progression over time.

Results: During the surveillance period, 34,572,554 COVID-19 cases were confirmed, among whom 38,112 (0.11%) progressed to severe/critical conditions. Most severe/critical cases occurred in individuals aged ≥60 years, with a notable increase in patients aged ≥80 years from 2022. The overall severity rate was 0.19%, with a fatality rate of 0.10%. However, the severity of cases gradually diminished during the study period. In 2022, the severity and fatality rates decreased to 0.14% and 0.09%, respectively. In 2023, while the severity rate remained stable at 0.15%, the fatality rate further decreased to 0.06%. Notably, throughout the study period, individuals aged ≥80 years had a significantly higher severity rate (2.44%), with a fatality rate of 1.75%.

Conclusion: These findings underscore the importance of prioritizing protection and management strategies for older adults and high-risk groups to mitigate the impact of COVID-19. Continued surveillance and analysis are essential to effectively control COVID-19 and minimize its burden on public health.

目的:我们分析了被诊断为2019冠状病毒病(COVID-19)的患者的人口学和临床特征,特别关注重症/危重病例,并评估了韩国这些患者的趋势和严重程度和病死率。方法:收集2020年1月20日至2023年8月30日韩国疾病管理院数据库中COVID-19患者的临床资料。我们确定了进展为严重/危重症的患者,并分析了他们的人口统计学和临床资料。每年计算和比较严重程度和死亡率,以跟踪疾病随时间的进展。结果:监测期间累计确诊病例34572554例,其中重症/危重症38112例(0.11%)。大多数严重/危重病例发生在≥60岁的个体中,从2022年开始,≥80岁的患者显著增加。总严重度为0.19%,病死率为0.10%。然而,在研究期间,病例的严重程度逐渐降低。2022年,严重程度和死亡率分别降至0.14%和0.09%。2023年,重症率稳定在0.15%,病死率进一步下降至0.06%。值得注意的是,在整个研究期间,年龄≥80岁的个体的严重程度明显更高(0.19%),病死率为1.75%。结论:这些发现强调了优先考虑老年人和高危人群的保护和管理策略以减轻COVID-19影响的重要性。持续监测和分析对于有效控制COVID-19并尽量减少其对公共卫生的负担至关重要。
{"title":"Characteristics and trends of severe/critical COVID-19 cases in the Republic of Korea (January 2020 to August 2023).","authors":"Se-Jin Jeong, Shin Young Park, Boyeong Ryu, Misuk An, Jin-Hwan Jeon, So Young Choi, Seong-Sun Kim","doi":"10.24171/j.phrp.2024.0295","DOIUrl":"10.24171/j.phrp.2024.0295","url":null,"abstract":"<p><strong>Background: </strong>We analyzed the demographic and clinical characteristics of patients diagnosed with coronavirus disease 2019 (COVID-19), focusing specifically on severe/critical cases, and assessed the trends and rates of severity and fatality among these patients in the Republic of Korea.</p><p><strong>Methods: </strong>Clinical data on patients with COVID-19 from January 20, 2020 to August 30, 2023 were collected from the Korea Disease Control and Prevention Agency's database. We identified patients who progressed to severe/critical conditions and analyzed their demographic and clinical profiles. Severity and fatality rates were calculated and compared annually to track the disease progression over time.</p><p><strong>Results: </strong>During the surveillance period, 34,572,554 COVID-19 cases were confirmed, among whom 38,112 (0.11%) progressed to severe/critical conditions. Most severe/critical cases occurred in individuals aged ≥60 years, with a notable increase in patients aged ≥80 years from 2022. The overall severity rate was 0.19%, with a fatality rate of 0.10%. However, the severity of cases gradually diminished during the study period. In 2022, the severity and fatality rates decreased to 0.14% and 0.09%, respectively. In 2023, while the severity rate remained stable at 0.15%, the fatality rate further decreased to 0.06%. Notably, throughout the study period, individuals aged ≥80 years had a significantly higher severity rate (2.44%), with a fatality rate of 1.75%.</p><p><strong>Conclusion: </strong>These findings underscore the importance of prioritizing protection and management strategies for older adults and high-risk groups to mitigate the impact of COVID-19. Continued surveillance and analysis are essential to effectively control COVID-19 and minimize its burden on public health.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"81-88"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143366119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of a brain exercise program using game-based cognitive enhancement to reduce mild cognitive impairment among older adults in Pathum Thani Province, Thailand: a quasi-experimental study. 在泰国巴吞他尼省的老年人中,使用基于游戏的认知增强来减少轻度认知障碍的脑锻炼计划的有效性:一项准实验研究。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2025-02-17 DOI: 10.24171/j.phrp.2024.0267
Panida Kunrit, Phannathat Tanthanapanyakorn, Nonlapan Khantikulanon, Sootthikarn Mungkhunthod, Chaninan Praserttai, Sasipa Rungrungrueang, Wanwisa Phonmamuang

Background: Mild cognitive impairment (MCI) is prevalent among older adults and may progress to dementia. This study evaluated the effectiveness of a game-based brain exercise program in reducing MCI among older adults.

Methods: A quasi-experimental study was conducted with 2 groups of older participants in Pathum Thani Province, Thailand. A total of 96 individuals with Thai mental state examination (TMSE) scores between 12 to 23, indicating MCI but no dementia diagnosis, were recruited. Using multi-stage sampling, participants were divided into an intervention group (n=48) and a control group (n=48). The intervention group participated in a 6-week game-based brain exercise program, while the control group received a self-administered brain exercise manual. Face-to-face interviews assessed outcomes at baseline, post-intervention, and 3-month follow-up. Data were analyzed using descriptive statistics and repeated-measures analysis of variance.

Results: Significant differences were observed in mean TMSE scores and MCI knowledge between the intervention and control groups at the 3-month follow-up (p<0.001). The intervention group showed significant increases in TMSE scores and MCI knowledge post-intervention and at 3-month follow-up (p<0.001).

Conclusion: The findings suggest that a game-based brain exercise program can improve cognitive function in older adults. Healthcare professionals can implement such programs to reduce MCI by addressing planning, management, and related issues in the future.

目的:轻度认知障碍(MCI)在老年人中普遍存在,并可能发展为痴呆。本研究评估了以游戏为基础的大脑锻炼项目在减少老年人轻度认知障碍方面的有效性。方法:对泰国巴吞他尼省两组老年人进行准实验研究。总共招募了96名泰国精神状态检查(TMSE)得分在12至23之间的个体,表明MCI但没有痴呆诊断。采用多阶段抽样法,将参与者分为干预组(n=48)和对照组(n=48)。干预组参加了一个为期6周的以游戏为基础的大脑锻炼项目,而对照组则接受了一份自我管理的大脑锻炼手册。面对面访谈评估了基线、干预后和3个月随访的结果。数据分析采用描述性统计和重复测量方差分析。结果:在3个月的随访中,干预组和对照组在平均TMSE得分和MCI知识方面存在显著差异(p)。结论:研究结果表明,基于游戏的大脑锻炼计划可以改善老年人的认知功能。医疗保健专业人员可以实施这样的方案,通过解决计划、管理和未来的相关问题来减少MCI。
{"title":"Effectiveness of a brain exercise program using game-based cognitive enhancement to reduce mild cognitive impairment among older adults in Pathum Thani Province, Thailand: a quasi-experimental study.","authors":"Panida Kunrit, Phannathat Tanthanapanyakorn, Nonlapan Khantikulanon, Sootthikarn Mungkhunthod, Chaninan Praserttai, Sasipa Rungrungrueang, Wanwisa Phonmamuang","doi":"10.24171/j.phrp.2024.0267","DOIUrl":"10.24171/j.phrp.2024.0267","url":null,"abstract":"<p><strong>Background: </strong>Mild cognitive impairment (MCI) is prevalent among older adults and may progress to dementia. This study evaluated the effectiveness of a game-based brain exercise program in reducing MCI among older adults.</p><p><strong>Methods: </strong>A quasi-experimental study was conducted with 2 groups of older participants in Pathum Thani Province, Thailand. A total of 96 individuals with Thai mental state examination (TMSE) scores between 12 to 23, indicating MCI but no dementia diagnosis, were recruited. Using multi-stage sampling, participants were divided into an intervention group (n=48) and a control group (n=48). The intervention group participated in a 6-week game-based brain exercise program, while the control group received a self-administered brain exercise manual. Face-to-face interviews assessed outcomes at baseline, post-intervention, and 3-month follow-up. Data were analyzed using descriptive statistics and repeated-measures analysis of variance.</p><p><strong>Results: </strong>Significant differences were observed in mean TMSE scores and MCI knowledge between the intervention and control groups at the 3-month follow-up (p<0.001). The intervention group showed significant increases in TMSE scores and MCI knowledge post-intervention and at 3-month follow-up (p<0.001).</p><p><strong>Conclusion: </strong>The findings suggest that a game-based brain exercise program can improve cognitive function in older adults. Healthcare professionals can implement such programs to reduce MCI by addressing planning, management, and related issues in the future.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"59-71"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The global prevalence of autism spectrum disorder in children: a systematic review and meta-analysis. 儿童自闭症谱系障碍的全球患病率:系统回顾和荟萃分析。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2025-02-10 DOI: 10.24171/j.phrp.2024.0286
Alwin Issac, Kurvatteppa Halemani, Asha Shetty, Latha Thimmappa, V R Vijay, Kiranmayi Koni, Prabhaker Mishra, Vishwas Kapoor

Background: The objective of this review was to analyze quantitative data on autism spectrum disorder (ASD) and to increase the accuracy of estimates of the prevalence of ASD.

Methods: This review, which was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, included studies conducted from January 2008 to June 2024 on children aged 3 to 18 years that used standardized measurement tools and reported cut-off scores for ASD. The prevalence of ASD was the primary outcome analyzed in this review. The PubMed, Clinical Key, Scopus, Embase, CINAHL, and Web of Science databases were reviewed for relevant studies. The review protocol was registered with PROSPERO and followed the Cochrane collaboration guidelines.

Results: A total of 66 studies reported on the prevalence of ASD, screening 21,313,061 children worldwide. Among these, 25 studies were conducted in Europe, 22 in Asia, and 13 in America. Additionally, 3 studies each were reported from Africa and Australia. According to a meta-analysis, 0.77% of children globally are diagnosed with ASD, with boys comprising 1.14% of this group. Notably, Australia showed the highest prevalence rate, with an effect size of 2.18, highlighting it as a critical area for public health focus.

Conclusion: ASD represents a significant global health burden. Early detection, increased awareness among parents, and prompt intervention are crucial for mitigating developmental problems in children later in life. It is essential for health policymakers to acknowledge the prevalence and growing trends of ASD in order to implement effective interventions.

目的:本综述的目的是分析自闭症谱系障碍(ASD)的定量数据,并提高ASD患病率估计的准确性。方法:本综述根据系统评价和荟萃分析声明的首选报告项目进行报道,包括2008年1月至2024年6月对3至18岁儿童进行的研究,这些研究使用标准化测量工具并报告ASD的截止分数。ASD的患病率是本系统综述和荟萃分析的主要结果。对PubMed、Clinical Key、Scopus、Embase、CINAHL和Web of Science数据库进行了相关研究综述。该评价方案已在PROSPERO注册,并遵循Cochrane合作指南。数据手工输入到Excel中,并使用Stata软件进行分析。17.结果:共有66项研究报道了ASD的患病率,全球筛查了21,313,061名儿童。其中欧洲25项,亚洲22项,美洲13项。此外,非洲和澳大利亚各报告了3项研究。根据一项荟萃分析,全球0.77%的儿童被诊断为自闭症谱系障碍,其中男孩占1.14%。值得注意的是,澳大利亚的患病率最高,效应值为2.18,突出表明澳大利亚是公共卫生重点关注的一个关键领域。结论:自闭症谱系障碍是一个重大的全球健康负担。早期发现、提高父母的认识和及时干预对于减轻儿童以后的发育问题至关重要。为了实施有效的干预措施,卫生政策制定者必须认识到自闭症谱系障碍的患病率和增长趋势。
{"title":"The global prevalence of autism spectrum disorder in children: a systematic review and meta-analysis.","authors":"Alwin Issac, Kurvatteppa Halemani, Asha Shetty, Latha Thimmappa, V R Vijay, Kiranmayi Koni, Prabhaker Mishra, Vishwas Kapoor","doi":"10.24171/j.phrp.2024.0286","DOIUrl":"10.24171/j.phrp.2024.0286","url":null,"abstract":"<p><strong>Background: </strong>The objective of this review was to analyze quantitative data on autism spectrum disorder (ASD) and to increase the accuracy of estimates of the prevalence of ASD.</p><p><strong>Methods: </strong>This review, which was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, included studies conducted from January 2008 to June 2024 on children aged 3 to 18 years that used standardized measurement tools and reported cut-off scores for ASD. The prevalence of ASD was the primary outcome analyzed in this review. The PubMed, Clinical Key, Scopus, Embase, CINAHL, and Web of Science databases were reviewed for relevant studies. The review protocol was registered with PROSPERO and followed the Cochrane collaboration guidelines.</p><p><strong>Results: </strong>A total of 66 studies reported on the prevalence of ASD, screening 21,313,061 children worldwide. Among these, 25 studies were conducted in Europe, 22 in Asia, and 13 in America. Additionally, 3 studies each were reported from Africa and Australia. According to a meta-analysis, 0.77% of children globally are diagnosed with ASD, with boys comprising 1.14% of this group. Notably, Australia showed the highest prevalence rate, with an effect size of 2.18, highlighting it as a critical area for public health focus.</p><p><strong>Conclusion: </strong>ASD represents a significant global health burden. Early detection, increased awareness among parents, and prompt intervention are crucial for mitigating developmental problems in children later in life. It is essential for health policymakers to acknowledge the prevalence and growing trends of ASD in order to implement effective interventions.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"3-27"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917377/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143400305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of tobacco, alcohol, stimulant, khat, and cannabis use among school-going students in African and Arab countries: a systematic review and meta-analysis. 非洲和阿拉伯国家在校学生使用烟草、酒精、兴奋剂、卡塔叶和大麻的流行率:系统回顾和荟萃分析。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2024-12-13 DOI: 10.24171/j.phrp.2024.0204
Chaimaa El Moubchiri, Mohamed Chahboune, Morad Guennouni, Abderraouf Hilali

Background: The objectives of this review and meta-analysis were twofold: first, to determine the prevalence of substance use among school-going children in Arab and African countries; and second, to highlight the considerable influence of variables such as the nation's region and the timeframe of the study on the prevalence of substance use.

Methods: Research was sourced from Science Direct, Scopus, Web of Science, Google Scholar, and PubMed. Thirty-seven articles were incorporated in accordance with the PRISMA guidelines. This review included studies published from 2013 to 2023. The statistical meta-analysis was performed using Comprehensive Meta-Analysis ver. 3 software. Across 37 studies, the total number of study participants was 73,508.

Results: The meta-analysis revealed that tobacco was the most commonly used substance, with a prevalence of 16% (95% confidence interval [CI], 12.7%-20.02%). This was closely followed by alcohol, which had a prevalence of 15% (95% CI, 10.5%-22.8%), stimulants at 11.4% (95% CI, 7.4%-17%), khat at 10% (95% CI, 5.7%-15%), and cannabis at 8% (95% CI, 3.3%-18.4%). Notably, alcohol was the only substance that showed an increasing trend in prevalence from before to after 2019, rising from 13.3% (95% CI, 6.2%-26.1%) to 17% (95% CI, 10.2%-27%) (p<0.001). Additionally, the prevalence of substance use varied significantly between Arab and African countries (p<0.001).

Conclusion: Although the prevalence of substance use among school-going populations has significantly decreased over time, with the exception of alcohol, it is imperative that both African and Arab countries implement comprehensive measures and stringent laws to address the production and marketing of substances.

目的:本综述和荟萃分析的目的有两个:首先,确定阿拉伯和非洲国家学龄儿童中药物使用的流行程度;其次,强调国家区域和研究时间框架等变量对药物使用流行率的重大影响。方法:研究来源于Science Direct、Scopus、Web of Science、谷歌Scholar和PubMed。根据PRISMA准则纳入了37条条款。该综述纳入了2013年至2023年发表的研究。统计荟萃分析采用综合荟萃分析软件。3软件。在37项研究中,研究参与者总数为73,508人。结果:荟萃分析显示,烟草是最常用的物质,患病率为16%(95%置信区间[CI], 12.7%-20.02%)。紧随其后的是酒精,其患病率为15% (95% CI, 10.5%-22.8%),兴奋剂为11.4% (95% CI, 7.4%- 17%),阿拉伯茶为10% (95% CI, 5.7%-15%),大麻为8% (95% CI, 3.3%-18.4%)。值得注意的是,酒精是2019年前后唯一呈现出患病率上升趋势的物质,从13.3% (95% CI, 6.2%-26.1%)上升到17% (95% CI, 10.2%-27%) (p< 0.001)。此外,阿拉伯国家和非洲国家之间的药物使用流行率差异显著(p< 0.001)。结论:虽然学龄人口中药物使用率随着时间的推移显著下降,但酒精除外,但非洲和阿拉伯国家都必须实施全面措施和严格的法律,以解决药物的生产和销售问题。
{"title":"The prevalence of tobacco, alcohol, stimulant, khat, and cannabis use among school-going students in African and Arab countries: a systematic review and meta-analysis.","authors":"Chaimaa El Moubchiri, Mohamed Chahboune, Morad Guennouni, Abderraouf Hilali","doi":"10.24171/j.phrp.2024.0204","DOIUrl":"10.24171/j.phrp.2024.0204","url":null,"abstract":"<p><strong>Background: </strong>The objectives of this review and meta-analysis were twofold: first, to determine the prevalence of substance use among school-going children in Arab and African countries; and second, to highlight the considerable influence of variables such as the nation's region and the timeframe of the study on the prevalence of substance use.</p><p><strong>Methods: </strong>Research was sourced from Science Direct, Scopus, Web of Science, Google Scholar, and PubMed. Thirty-seven articles were incorporated in accordance with the PRISMA guidelines. This review included studies published from 2013 to 2023. The statistical meta-analysis was performed using Comprehensive Meta-Analysis ver. 3 software. Across 37 studies, the total number of study participants was 73,508.</p><p><strong>Results: </strong>The meta-analysis revealed that tobacco was the most commonly used substance, with a prevalence of 16% (95% confidence interval [CI], 12.7%-20.02%). This was closely followed by alcohol, which had a prevalence of 15% (95% CI, 10.5%-22.8%), stimulants at 11.4% (95% CI, 7.4%-17%), khat at 10% (95% CI, 5.7%-15%), and cannabis at 8% (95% CI, 3.3%-18.4%). Notably, alcohol was the only substance that showed an increasing trend in prevalence from before to after 2019, rising from 13.3% (95% CI, 6.2%-26.1%) to 17% (95% CI, 10.2%-27%) (p<0.001). Additionally, the prevalence of substance use varied significantly between Arab and African countries (p<0.001).</p><p><strong>Conclusion: </strong>Although the prevalence of substance use among school-going populations has significantly decreased over time, with the exception of alcohol, it is imperative that both African and Arab countries implement comprehensive measures and stringent laws to address the production and marketing of substances.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"28-41"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excess mortality in older adults and cumulative excess mortality across all ages during the COVID-19 pandemic in the 20 countries with the highest mortality rates worldwide. 在全球20个死亡率最高的国家中,2019冠状病毒病大流行期间老年人的超额死亡率和所有年龄段的累计超额死亡率。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-01 Epub Date: 2025-02-13 DOI: 10.24171/j.phrp.2024.0186
Chiranjib Chakraborty, Manojit Bhattacharya, Sang-Soo Lee

Background: Mortality statistics during the coronavirus disease 2019 (COVID-19) pandemic are crucial for the allocation of medical care resources and public health decision-making. This study was initiated to investigate the excess mortality among older adults during the pandemic. Our research focuses on 2 primary areas. First, we analyzed the cumulative excess mortality across all age groups to assess the global impact and specifically examined the top 20 countries with the highest mortality rates during the pandemic. Second, we explored excess deaths among older adults by categorizing data from the years 2020 and 2021 into age groups: 65-74, 75-84, and above 85.

Methods: We analyzed data from the top 20 countries with the highest mortality rates globally, focusing on 3 components: all-cause mortality means, expected deaths mean, and excess deaths mean for both older men and women.

Results: Although excess mortality is higher among older men and women across all 3 age groups (65-74, 75-84, and >85), the highest mean excess mortality was observed in women over the age of 85.

Conclusion: The results indicate that the severe acute respiratory syndrome coronavirus 2 virus had a disproportionately intense impact on older women. We developed 2 types of statistical models using the data: a binomial distribution model and a correlation coefficient model, both considering the mean excess deaths in older men and women across these 3 age groups. Estimating the excess mortality among older adults will aid in the formulation of healthcare policies for this demographic.

目的:2019冠状病毒病(COVID-19)大流行期间的死亡率统计数据对医疗资源分配和公共卫生决策至关重要。开展这项研究是为了调查大流行期间老年人的过高死亡率。我们的研究主要集中在两个方面。首先,我们分析了所有年龄组的累积超额死亡率,以评估全球影响,并具体检查了大流行期间死亡率最高的前20个国家。其次,我们通过将2020年和2021年的数据分类为65-74岁、75-84岁和85岁以上的年龄组,探讨了老年人的超额死亡。方法:我们分析了全球死亡率最高的前20个国家的数据,重点关注3个组成部分:老年男性和女性的全因死亡率均值、预期死亡均值和超额死亡均值。结果:尽管在所有3个年龄组(65-74岁、75-84岁和85岁)中,老年男性和女性的超额死亡率较高,但在85岁以上的女性中,平均超额死亡率最高。结论:结果表明,严重急性呼吸综合征冠状病毒2型对老年妇女的影响尤为严重。我们利用这些数据建立了两种类型的统计模型:二项分布模型和相关系数模型,两者都考虑了这三个年龄组中老年男性和女性的平均超额死亡率。估计老年人的超额死亡率将有助于制定针对这一人口的医疗保健政策。
{"title":"Excess mortality in older adults and cumulative excess mortality across all ages during the COVID-19 pandemic in the 20 countries with the highest mortality rates worldwide.","authors":"Chiranjib Chakraborty, Manojit Bhattacharya, Sang-Soo Lee","doi":"10.24171/j.phrp.2024.0186","DOIUrl":"10.24171/j.phrp.2024.0186","url":null,"abstract":"<p><strong>Background: </strong>Mortality statistics during the coronavirus disease 2019 (COVID-19) pandemic are crucial for the allocation of medical care resources and public health decision-making. This study was initiated to investigate the excess mortality among older adults during the pandemic. Our research focuses on 2 primary areas. First, we analyzed the cumulative excess mortality across all age groups to assess the global impact and specifically examined the top 20 countries with the highest mortality rates during the pandemic. Second, we explored excess deaths among older adults by categorizing data from the years 2020 and 2021 into age groups: 65-74, 75-84, and above 85.</p><p><strong>Methods: </strong>We analyzed data from the top 20 countries with the highest mortality rates globally, focusing on 3 components: all-cause mortality means, expected deaths mean, and excess deaths mean for both older men and women.</p><p><strong>Results: </strong>Although excess mortality is higher among older men and women across all 3 age groups (65-74, 75-84, and >85), the highest mean excess mortality was observed in women over the age of 85.</p><p><strong>Conclusion: </strong>The results indicate that the severe acute respiratory syndrome coronavirus 2 virus had a disproportionately intense impact on older women. We developed 2 types of statistical models using the data: a binomial distribution model and a correlation coefficient model, both considering the mean excess deaths in older men and women across these 3 age groups. Estimating the excess mortality among older adults will aid in the formulation of healthcare policies for this demographic.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"42-58"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11917389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea. 大韩民国 18 岁以上人群接种二价 COVID-19 mRNA 强化疫苗的安全性。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-01 Epub Date: 2024-10-29 DOI: 10.24171/j.phrp.2024.0194
Seok-Kyoung Choi, Seontae Kim, Mijeong Ko, Yeseul Heo, Tae Eun Kim, Yeonkyeong Lee, Juyeon Jang, Eunok Bahng

Background: The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea.

Methods: Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older. Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey.

Results: Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia.

Conclusion: Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.

研究目的本研究旨在传播有关大韩民国成人接种的2019年冠状病毒病(COVID-19)mRNA强化疫苗安全性的信息:方法:使用两个数据库评估18岁及以上成人接种辉瑞BA.1、辉瑞BA.4/5、Moderna BA.1和Moderna BA.4/5的COVID-19加强剂疫苗的安全性。不良事件(AEs)的分析采用了向基于网络的COVID-19疫苗接种管理系统(CVMS)报告的数据和自我报告的短信调查:2022年10月11日至2023年3月30日期间,CVMS共收到2369例(93.7%)非严重AE报告,其中158例(6.3%)为严重AE,包括5例过敏性休克和33例死亡。从2022年10月11日至2023年1月27日,40,022名18岁及以上的人回复了通过短信进行的调查。与原始疫苗相比,加强剂量的局部和全身AEs较少。接种二价疫苗后,最常报告的不良反应是注射部位疼痛、头痛、疲劳和肌痛:总的来说,二价疫苗的不良反应少于原种疫苗。在接种辉瑞和Moderna二价疫苗后的18岁及以上成年人中,大多数不良反应为非严重不良反应,而严重不良反应则很少见。
{"title":"Safety of the bivalent COVID-19 mRNA booster vaccination among persons aged over 18 years in the Republic of Korea.","authors":"Seok-Kyoung Choi, Seontae Kim, Mijeong Ko, Yeseul Heo, Tae Eun Kim, Yeonkyeong Lee, Juyeon Jang, Eunok Bahng","doi":"10.24171/j.phrp.2024.0194","DOIUrl":"10.24171/j.phrp.2024.0194","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to disseminate information about the safety of bivalent coronavirus disease 2019 (COVID-19) mRNA booster vaccines administered to adults in the Republic of Korea.</p><p><strong>Methods: </strong>Two databases were used to assess the safety of COVID-19 booster doses of Pfizer BA.1, Pfizer BA.4/5, Moderna BA.1, and Moderna BA.4/5 vaccines for adults aged 18 years and older. Adverse events (AEs) were analyzed using data reported to the web-based COVID-19 vaccination management system (CVMS) and a self-reported text-message survey.</p><p><strong>Results: </strong>Between October 11, 2022 and March 30, 2023, the CVMS received reports of 2,369 (93.7%) non-serious AEs from vaccinated adults, along with 158 (6.3%) serious AEs, which included 5 cases of anaphylaxis and 33 deaths. From October 11, 2022 to January 27, 2023, 40,022 people aged 18 and older responded to a survey conducted via text message. The booster doses were associated with fewer local and systemic AEs compared to the original vaccines. After receiving the bivalent vaccine, the most commonly reported AEs were pain at the injection site, headache, fatigue, and myalgia.</p><p><strong>Conclusion: </strong>Overall, bivalent vaccines exhibited fewer AEs compared to the original vaccines. The majority of AEs were non-serious, and serious AEs were rare among adults aged 18 years and older following vaccination with the Pfizer and Moderna bivalent vaccines.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"542-549"},"PeriodicalIF":2.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial. 补充绿咖啡对伊朗多囊卵巢综合征妇女体内副氧合酶-1活性和丙二醛水平的影响:一项随机临床试验。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-01 Epub Date: 2024-11-20 DOI: 10.24171/j.phrp.2024.0187
Azam Ildarabadi, Marzieh Vahid-Dastjerdi, Mina Ghorbanpour, Ahmad Mousavi, Mehrnoush Meshkani, Mirsaeed Yekaninejad, Ahmad Saedisomeolia

Background: Polycystic ovary syndrome (PCOS) is a common, heterogeneous clinical syndrome affecting women. Investigating oxidative stress in women is crucial, as it is linked to insulin resistance and endothelial dysfunction. Chlorogenic acid, a bioactive component found in green coffee, has numerous documented health benefits. This study aimed to assess the beneficial effects of green coffee consumption on paraoxonase-1 (PON-1) activity and malondialdehyde (MDA) levels in women with PCOS.

Methods: This study was a double-blind randomized clinical trial that included 44 patients with PCOS. Participants were randomly assigned to either the intervention or control group. For 6 weeks, the intervention group (n=22) received 400 mg of green coffee supplements, while the control group (n=22) received 400 mg of a starch-based placebo. Anthropometric indices, dietary assessments, and physical activity levels were evaluated before and after the 6-week intervention period. Additionally, blood samples were collected for laboratory analysis.

Results: Supplementation with green coffee increased PON-1 levels by 3.5 units, a significant finding (p=0.038). Additionally, the intake of green coffee supplements significantly reduced blood cholesterol levels by 18.8 units (p=0.013) and triglyceride levels by 6.1 units (p=0.053). However, no significant differences were observed in the levels of MDA, high-density lipoprotein, low-density lipoprotein, fasting blood sugar, insulin, or homeostatic model assessment of insulin resistance as a result of the intervention.

Conclusion: Supplementation with green coffee alters PON-1 activity and cholesterol levels in women with PCOS. However, it has no significant impact on MDA levels or glycemic status.

目的:多囊卵巢综合征(PCOS)是一种常见的、影响女性的异质性临床综合征。研究女性体内的氧化应激至关重要,因为它与胰岛素抵抗和内皮功能障碍有关。绿原酸是绿咖啡中的一种生物活性成分,有许多文献记载它对健康有益。本研究旨在评估饮用绿咖啡对多囊卵巢综合征女性体内副氧合酶-1(PON-1)活性和丙二醛(MDA)水平的有益影响:该研究是一项双盲随机临床试验,包括 44 名多囊卵巢综合症患者。参与者被随机分配到干预组或对照组。干预组(22 人)服用 400 毫克绿咖啡补充剂,对照组(22 人)服用 400 毫克淀粉类安慰剂,为期 6 周。在为期 6 周的干预期前后,对人体测量指数、饮食评估和体力活动水平进行了评估。此外,还采集了血液样本进行实验室分析:结果:补充绿咖啡可使 PON-1 水平提高 3.5 个单位,这一结果非常显著(p=0.038)。此外,摄入绿咖啡补充剂后,血液中的胆固醇水平明显降低了 18.8 个单位(p=0.013),甘油三酯水平降低了 6.1 个单位(p=0.053)。然而,在干预措施的作用下,MDA、高密度脂蛋白、低密度脂蛋白、空腹血糖、胰岛素或胰岛素抵抗的稳态模型评估水平均未出现明显差异:结论:补充绿咖啡可改变多囊卵巢综合征女性体内 PON-1 的活性和胆固醇水平。结论:补充绿咖啡可改变多囊卵巢综合症妇女的 PON-1 活性和胆固醇水平,但对 MDA 水平和血糖状况没有明显影响。
{"title":"Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial.","authors":"Azam Ildarabadi, Marzieh Vahid-Dastjerdi, Mina Ghorbanpour, Ahmad Mousavi, Mehrnoush Meshkani, Mirsaeed Yekaninejad, Ahmad Saedisomeolia","doi":"10.24171/j.phrp.2024.0187","DOIUrl":"10.24171/j.phrp.2024.0187","url":null,"abstract":"<p><strong>Background: </strong>Polycystic ovary syndrome (PCOS) is a common, heterogeneous clinical syndrome affecting women. Investigating oxidative stress in women is crucial, as it is linked to insulin resistance and endothelial dysfunction. Chlorogenic acid, a bioactive component found in green coffee, has numerous documented health benefits. This study aimed to assess the beneficial effects of green coffee consumption on paraoxonase-1 (PON-1) activity and malondialdehyde (MDA) levels in women with PCOS.</p><p><strong>Methods: </strong>This study was a double-blind randomized clinical trial that included 44 patients with PCOS. Participants were randomly assigned to either the intervention or control group. For 6 weeks, the intervention group (n=22) received 400 mg of green coffee supplements, while the control group (n=22) received 400 mg of a starch-based placebo. Anthropometric indices, dietary assessments, and physical activity levels were evaluated before and after the 6-week intervention period. Additionally, blood samples were collected for laboratory analysis.</p><p><strong>Results: </strong>Supplementation with green coffee increased PON-1 levels by 3.5 units, a significant finding (p=0.038). Additionally, the intake of green coffee supplements significantly reduced blood cholesterol levels by 18.8 units (p=0.013) and triglyceride levels by 6.1 units (p=0.053). However, no significant differences were observed in the levels of MDA, high-density lipoprotein, low-density lipoprotein, fasting blood sugar, insulin, or homeostatic model assessment of insulin resistance as a result of the intervention.</p><p><strong>Conclusion: </strong>Supplementation with green coffee alters PON-1 activity and cholesterol levels in women with PCOS. However, it has no significant impact on MDA levels or glycemic status.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"521-532"},"PeriodicalIF":2.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of brucellosis-causing pathogens with an emphasis on the prevalence of Brucella melitensis in the Republic of Korea: insights from a decade of pathogen surveillance (2014-2023), a retrospective study. 大韩民国布鲁氏菌病致病病原体评估,重点是布鲁氏菌的流行情况:病原体监测十年(2014-2023 年)的启示,一项回顾性研究。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-01 Epub Date: 2024-11-19 DOI: 10.24171/j.phrp.2024.0134
In-Sook Shin, Su-Gwon Roh, Byoung-Chul Gill, Young-Suk Kim, Kyung-Won Hwang

Background: The main Brucella species causing human infections in the Republic of Korea is Brucella abortus, which uses cattle as its host. However, since 2014, Brucella melitensis, which uses sheep and goats as hosts, has also been identified. This study investigated whether a shift has occurred in the predominant species of Brucella pathogens.

Methods: Brucellosis is a class 3 infectious disease requiring mandatory reporting and registration in the Korea Disease Control and Prevention Agency's infectious disease surveillance system (http://is.kdca.go.kr). Cases from 2014 to 2023 were studied, and whole-genome sequencing analysis was conducted using BruMLSA21.

Results: Out of 51 patients, males (45 patients, 88.2%) were predominantly affected. Twenty-five patients (49%) came from the livestock industry, and within the livestock sector group, the route of infection occurred exclusively through contact (25/25, 100%), whereas in other occupations, it was split between contact (9/26 patients, 34.6%) and ingestion (8/26 patients, 30.8%). Among the 31 patients who underwent Brucella culture tests, B. melitensis was found to be more prevalent than B. abortus (14 patients, 45.2% vs. 11 patients, 35.5%). In all cases where B. melitensis was isolated, the infections were of foreign origin, consistent with the results of BruMLSA21.

Conclusion: Regular monitoring of the causative agent of brucellosis is necessary due to its varying host preferences and antibiotic resistance. Furthermore, given the increasing prevalence of B. melitensis worldwide, changes in dietary habits (e.g., increased lamb consumption), and the increase in foreign workers and Chinese immigrants, a multi-ministerial One Health response will be required.

目的:在大韩民国,导致人类感染的布鲁氏菌主要是以牛为宿主的流产布鲁氏菌。然而,自 2014 年以来,也发现了以绵羊和山羊为宿主的梅里塔斯布鲁氏菌。本研究调查了布鲁氏菌病原体的主要种类是否发生了变化:布鲁氏菌病是韩国疾病预防控制机构传染病监测系统 (http://is.kdca.go.kr) 中要求强制报告和登记的 3 级传染病。研究了2014年至2023年的病例,并使用BruMLSA21进行了全基因组测序分析:在 51 名患者中,男性占多数(45 人,88.2%)。25名患者(49%)来自畜牧业,在畜牧业群体中,感染途径完全是通过接触(25/25,100%),而在其他职业中,感染途径分为接触(9/26,34.6%)和摄入(8/26,30.8%)。在接受布鲁氏菌培养检测的 31 名患者中,梅里特斯布鲁氏菌的感染率高于流产布鲁氏菌(14 名患者,45.2%;11 名患者,35.5%)。在所有分离到梅毒杆菌的病例中,感染均来自国外,这与 BruMLSA21 的结果一致:结论:由于布鲁氏菌对宿主的偏好和抗生素耐药性各不相同,因此有必要定期监测布鲁氏菌病的病原体。此外,鉴于布鲁氏菌在全球范围内的流行率不断上升、饮食习惯的改变(如羊肉消费量的增加)以及外籍工人和中国移民的增加,需要采取多部委的 "一个健康 "应对措施。
{"title":"Assessment of brucellosis-causing pathogens with an emphasis on the prevalence of Brucella melitensis in the Republic of Korea: insights from a decade of pathogen surveillance (2014-2023), a retrospective study.","authors":"In-Sook Shin, Su-Gwon Roh, Byoung-Chul Gill, Young-Suk Kim, Kyung-Won Hwang","doi":"10.24171/j.phrp.2024.0134","DOIUrl":"10.24171/j.phrp.2024.0134","url":null,"abstract":"<p><strong>Background: </strong>The main Brucella species causing human infections in the Republic of Korea is Brucella abortus, which uses cattle as its host. However, since 2014, Brucella melitensis, which uses sheep and goats as hosts, has also been identified. This study investigated whether a shift has occurred in the predominant species of Brucella pathogens.</p><p><strong>Methods: </strong>Brucellosis is a class 3 infectious disease requiring mandatory reporting and registration in the Korea Disease Control and Prevention Agency's infectious disease surveillance system (http://is.kdca.go.kr). Cases from 2014 to 2023 were studied, and whole-genome sequencing analysis was conducted using BruMLSA21.</p><p><strong>Results: </strong>Out of 51 patients, males (45 patients, 88.2%) were predominantly affected. Twenty-five patients (49%) came from the livestock industry, and within the livestock sector group, the route of infection occurred exclusively through contact (25/25, 100%), whereas in other occupations, it was split between contact (9/26 patients, 34.6%) and ingestion (8/26 patients, 30.8%). Among the 31 patients who underwent Brucella culture tests, B. melitensis was found to be more prevalent than B. abortus (14 patients, 45.2% vs. 11 patients, 35.5%). In all cases where B. melitensis was isolated, the infections were of foreign origin, consistent with the results of BruMLSA21.</p><p><strong>Conclusion: </strong>Regular monitoring of the causative agent of brucellosis is necessary due to its varying host preferences and antibiotic resistance. Furthermore, given the increasing prevalence of B. melitensis worldwide, changes in dietary habits (e.g., increased lamb consumption), and the increase in foreign workers and Chinese immigrants, a multi-ministerial One Health response will be required.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"489-496"},"PeriodicalIF":2.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Osong Public Health and Research Perspectives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1